Clinical Trials Directory

Trials / Completed

CompletedNCT03735043

Cardiac Output Monitoring by ccNexfin© in Pregnant Women

Continuous Non-invasive Cardiac Output, an Evaluation of ccNexfin© in a Pregnant Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Variations of cardiac output are frequent in pregnant women during obstetrical procedures, and may participate to poor foetal outcomes through decrease of uteroplacental bloodflow. Thus, monitoring maternal cardiac output appears of major interest, as it would open the way to early initiation of hemodynamic supportive management. The ccNexfin© is a non-invasive hemodynamic monitoring device, whose relevance for continuous monitoring of cardiac output has been reported in a non-pregnant population. The hypothesis is that ccNexfin© gives acceptable measurement of maternal cardiac output in pregnant women.

Conditions

Interventions

TypeNameDescription
DEVICEcardiac output by ccNexfin ©Measurement of cardiac output by ccNexfin © comparatively to transthoracic echocardiography Subjects participating to the study will be simultaneously measured for cardiac output by ccNexfin © and transthoracic echocardiography. Echocardiographic measurements of cardiac output will be blinded to values measured by ccNexfin ©. For each participant, a first measurement of cardiac output will be performed in the supine position and then after 1 minute of strict left lateral position.

Timeline

Start date
2019-07-02
Primary completion
2020-06-01
Completion
2020-06-01
First posted
2018-11-08
Last updated
2021-03-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03735043. Inclusion in this directory is not an endorsement.

Cardiac Output Monitoring by ccNexfin© in Pregnant Women (NCT03735043) · Clinical Trials Directory